'Morning After' Pill Judge Slams Feds for 'Nonsense' Age Restrictions

Orders FDA To Lift Rules for 'Plan B' Pill

By Reuters

Published May 07, 2013.
  • Print
  • Share Share

A federal judge criticized the U.S. Food and Drug Administration over its refusal to make emergency contraception available to girls of all ages without a prescription, saying the agency’s move to restrict distribution to consumers aged 15 and older was not realistic.

U.S. District Judge Edward Korman on April 5 ordered the FDA to lift age restrictions on all levonorgestrel-based emergency contraception - also known as the “morning-after” pill or “Plan B” - to prevent unwanted pregnancies.

At a hearing in Brooklyn, New York, on Tuesday, he said he would rule by the end of the week on the FDA’s request to stay the order, which is slated to take effect May 10. The FDA has appealed the ruling to the 2nd U.S. Circuit Court of Appeals in Manhattan.

“I do think there is a principle that is a dangerous one of a court ordering the FDA to approve a drug,” FDA Commissioner Margaret Hamburg told the Reuters Health Summit in New York on Monday ahead of the hearing. “You have to step back and look at this not just in terms of Plan B but in terms of the precedent.”

Late last month, the FDA said it would allow girls as young as 15 years old to buy Plan B One-Step contraception, made by a unit of Teva Pharmaceutical Industries Ltd, without a prescription. Cashiers will still have to verify the customer’s age before selling it. The agency said the move was based on data provided by Teva that showed girls of that age could safely use the drug without the intervention of a healthcare provider.

Korman called the decision “a lot of nonsense,” saying that 15- and 16-year-olds may not have photo identification needed to buy the drug.

The judge noted that the FDA’s restrictions still apply to other forms of emergency contraception, including a two-pill version of Plan B and its generic equivalents. These are only available to women 17 and older with identification.

Korman also questioned the timing of the decision, made one day before the FDA filed its notice of appeal of the April order.

“I’m convinced the only reason you decided it when it was decided was to sugarcoat this appeal,” Korman told a lawyer for the FDA, Farzin Franklin Amanat.

A lawyer for the plaintiffs, Janet Crepps of the Center for Reproductive Rights, countered that the different access rules for Plan B One-Step and other forms of emergency contraception had created a “convoluted” system for girls and women seeking the drug in its brand name and generic forms.

“That’s what happens when you let politicians instead of scientists make these decisions,” Korman replied.

Emergency contraceptives generally sell for $10 to $80. Although they can work as long as 120 hours after unprotected sex, they are most effective in the first 24 hours.

Asked about the ongoing court case, Teva Chief Executive Jeremy Levin said the company provides medicines where they are needed.

“I’m not interested in getting into politics,” he told the Reuters Health Summit. “The bottom line is that we believe we are providing an important medicine.”


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • Woody Allen on the situation in #Gaza: It's “a terrible, tragic thing. Innocent lives are lost left and right, and it’s a horrible situation that eventually has to right itself.”
  • "Mark your calendars: It was on Sunday, July 20, that the momentum turned against Israel." J.J. Goldberg's latest analysis on Israel's ground operation in Gaza:
  • What do you think?
  • "To everyone who is reading this article and saying, “Yes, but… Hamas,” I would ask you to just stop with the “buts.” Take a single moment and allow yourself to feel this tremendous loss. Lay down your arms and grieve for the children of Gaza."
  • Professor Dan Markel, 41 years old, was found shot and killed in his Tallahassee home on Friday. Jay Michaelson can't explain the death, just grieve for it.
  • Employees complained that the food they received to end the daily fast during the holy month of Ramadan was not enough (no non-kosher food is allowed in the plant). The next day, they were dismissed.
  • Why are peace activists getting beat up in Tel Aviv? http://jd.fo/s4YsG
  • Backstreet's...not back.
  • Before there was 'Homeland,' there was 'Prisoners of War.' And before there was Claire Danes, there was Adi Ezroni. Share this with 'Homeland' fans!
  • BREAKING: Was an Israeli soldier just kidnapped in Gaza? Hamas' military wing says yes.
  • What's a "telegenically dead" Palestinian?
  • 13 Israeli soldiers die in Gaza — the deadliest day for the IDF in decades. So much for 'precision' strikes and easy exit strategies.
  • What do a Southern staple like okra and an Israeli favorite like tahini have in common? New Orleans chef Alon Shaya brings sabra tastes to the Big Easy.
  • The Cossacks were a feature in every European Jewish kid's worst nightmare. Tuvia Tenenbom went looking for the real-life variety in Ukraine — but you won't believe what he found. http://forward.com/articles/202181/my-hunt-for-the-cossacks-in-ukraine/?
  • French Jews were stunned when an anti-Israel mob besieged a synagogue outside Paris. What happened next could be a historic turning point.
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.